glp 1 boehringer advances #first #triple #agonist #bi3034701 #obesity #pipeline #glp #gip #npy2 #glucagon #glp #boehringeringelheim #obesity #glp1 #gip #npy2 #cardiometabolic #phase2 #clinicaltrials #drugdevelopment… Boehringer dual-acting obesity shot hits
Pay in 4 interest-free payments of $6.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

























